Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on International Tech Times.
Press releases published on May 12, 2025
TPI Composites, Inc. Announces First Quarter 2025 Earnings Results – Operational Execution and Strategic Initiatives Drive Improved Financial Results; Initiation of Strategic Review
GlobeNewswire
·
May 12, 2025
SCOTTSDALE, Ariz., May 12, 2025 (GLOBE NEWSWIRE) -- TPI Composites, Inc. (Nasdaq: TPIC), today reported financial results for the first quarter ended March 31, 2025. TPI further announced that its Board of Directors has initiated a strategic review of the …
FibroGen Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 12, 2025
Total consideration for the sale of FibroGen China to AstraZeneca now expected to be approximately $185 million, a $25 million increase from initial guidance Net cash held in China at closing now estimated to be approximately $100 million Transaction …
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 Financial Results
GlobeNewswire
·
May 12, 2025
Completed enrollment in Phase 2 MaGic trial of DNTH103 in generalized Myasthenia Gravis (gMG) Top-line MaGic results anticipated in September 2025 to be the first of three catalysts for the DNTH103 neuromuscular franchise by YE’26 Phase 3 CAPTIVATE trial …
Neumora Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 12, 2025
On track to report topline data from NMRA-511 in Alzheimer’s disease agitation around the end of 2025 Resumed enrollment for KOASTAL-3 and -2 studies in March 2025; anticipate reporting topline major depressive disorder data from KOASTAL-3 in the first …
Aquestive Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 12, 2025
Submitted NDA for Anaphylm™ (epinephrine), the first and only oral sublingual film for patients with severe allergic reactions Advancing commercial readiness efforts with a planned Q1 2026 launch of Anaphylm, subject to FDA approval Company to host …
Assertio Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 12, 2025
First Quarter Total Net Product Sales of $26.0 Million, In Line with 2025 Outlook Provides Update on Long-Term Business Strategy Designed to Create Sustainable Near-Term Growth and Increased Long-Term Value LAKE FOREST, Ill., May 12, 2025 (GLOBE NEWSWIRE) …
Relmada Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 12, 2025
Positive initial Phase 2 proof-of-concept data for NDV-01 at AUA 2025 showing a 90% overall response rate at any time in non-muscle invasive bladder cancer (US prevalence 600K patients) The Phase 2 study for NDV-01 continues with updates at 6, 9 and 12 …
CompoSecure Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 12, 2025
Operating results in line with expectations Reiterating previously issued full-year 2025 guidance Completed spin-off of Resolute Holdings Management, Inc. (Nasdaq: RHLD) Accounting standards related to the spin-off require the Company to report results …
Syndax Pharmaceuticals Appoints Dr. Nicholas Botwood as Head of Research and Development and Chief Medical Officer
GlobeNewswire
·
May 12, 2025
- Dr. Nicholas Botwood comes to Syndax from BMS and brings 25 years of industry experience leading drug development, R…
Plug Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 12, 2025
SLINGERLANDS, N.Y., May 12, 2025 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions, today announced its financial results and operational milestones for the first quarter ended March 31, 2025. The …
Editas Medicine Announces U.S. Court of Appeals for the Federal Circuit Remands CRISPR Patent Interference to Patent Trial and Appeal Board
GlobeNewswire
·
May 12, 2025
CAMBRIDGE, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company, today announced that the U.S. Court of Appeals for the Federal Circuit affirmed-in-part and vacated-in-part the Patent Trial and …
Jeff Timmons of 98 Degrees Taps CYPFER for Elite Digital Protection
EIN Presswire
·
May 12, 2025
Music Industry Veteran Embraces Cyber Certainty™ to Safeguard His Creative Legacy and Personal Brand MIAMI, FL, UNITED STATES, May 12, 2025 /EINPresswire.com/ -- CYPFER, a global cybersecurity powerhouse, proudly announces its latest collaboration with …
MoonLake Immunotherapeutics Reports First Quarter 2025 Financial Results and Provides a Business Update
GlobeNewswire
·
May 12, 2025
MoonLake Immunotherapeutics Reports First Quarter 2025 Financial Results and Provides a Business Update Continued to make significant progress with the development of the Nanobody® sonelokimab across portfolio of indications, including Phase 3 studies in …
Quest Resource Holding Corporation Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 12, 2025
Operating performance in line with expectations Sale of non-core business for $5 million used to pay down debt Savings of $3 million annually through elimination of costs associated with sold non-core business, and reduction of headcount Amended agreements …
SourceLess Expands Its Innovation Footprint: Five Core Technologies Now Live and Operational
EIN Presswire
·
May 12, 2025
SourceLess Inc. activates its five core technologies, moving from concept to reality with live, integrated solutions across Web3, AI, and finance. DELAWARE, DE, UNITED STATES, May 12, 2025 /EINPresswire.com/ -- More than a year after its first major …
Siren Biotechnology to Present Universal AAV Immuno-Gene Therapy Data at the 2025 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
GlobeNewswire
·
May 12, 2025
SAN FRANCISCO, May 12, 2025 (GLOBE NEWSWIRE) -- Siren Biotechnology Inc., pioneers of Universal AAV Immuno-Gene Therapy for Cancer, today announced that it will present new scientific data at the 2025 American Society of Gene and Cell Therapy (ASGCT) …
Toll Brothers to Host Model Home Grand Opening at its Venado Valley Community in Carson City, Nevada on May 17
GlobeNewswire
·
May 12, 2025
CARSON CITY, Nev., May 12, 2025 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced the grand opening of Venado Valley, a new luxury home community in Carson City, Nevada. This private enclave …
Pace-O-Matic presents inaugural Integrity Award to Larry Hilimire
GlobeNewswire
·
May 12, 2025
DULUTH, Ga., May 12, 2025 (GLOBE NEWSWIRE) -- Pace-O-Matic and its founder, Michael Pace, have presented the first-ever Integrity Award to Larry Hilimire, amusement industry legend and owner of Staunton Automatics in New York. The award was presented to …
SONEXOS APPOINTS ANDREA ONETTI AS CHIEF OPERATING OFFICER TO LEAD GLOBAL OPERATIONS & COMMERCIALIZATION OF PLASMAPANEL
EIN Presswire
·
May 12, 2025
Respected Leader in Audio Electronics to Drive Market Expansion of Sonexos’ AI-Driven Solid-State Active Noise Control Solutions LAUSANNE, VAUD, SWITZERLAND, May 12, 2025 /EINPresswire.com/ -- Sonexos, a pioneer in solid-state active noise control …
Neumonda unveils Octopus DRAM tester tailored for the testing and qualification of DRAM components for memory modules
EIN Presswire
·
May 12, 2025
The test board was designed with the help of Kontron and will be available in Q3 2025 FRANKFURT / BAD HOMBURG, GERMANY, May 12, 2025 /EINPresswire.com/ -- Neumonda Technology launches its newest DRAM test board, code-named Octopus. Neumonda’s Octopus …